Nursing Care of Patients with Chronic Kidney Disease Infected with COVID-19 in Critically ill Condition

Authors

  • Nudchaporn Doommai , Burapha University
  • Chantira Chiaranai School of Adult and Elderly Nursing, Institute of Nursing, Suranaree University of Technology

Keywords:

chronic kidney disease, COVID-19, critically ill patients, nursing

Abstract

       Introduction: The coronavirus disease 2019 (COVID-19) pandemic situation is an international public health emergency because it rapidly spreads and causes many consequences to patients, especially, its  impact on health conditions of patients with chronic kidney disease (CKD).  When these patients are infected with COVID-19, it  leads to complex health problems and life-threatening critical illnesses.     

Objectives: This article aimed to present nursing care for patients with CKD infected with COVID-19 regarding 4 issues as follows: 1) pathology of COVID-19, 2) COVID-19 induced kidney function and CKD, 3) treatment for patients with CKD infected with COVID-19 in a critical phase, and 4) role of nurses in the care of patients with CKD infected with COVID-19 in a critical phase.

Key issues: CKD is a major risk factor that results in people being infected with COVID-19 suffering from severe illness due to inflammation which causes severe infection leading to acute kidney injury. If CKD patients who are infected with COVID-19 do not receive the proper treatments, the severe complication can be a leading cause of death in a  short period of time.  Caring principle for these patients requires conservative treatments to maintain their kidney function as well as renal replacement therapy, particularly in patients whose kidneys can no longer function. Nurses therefore play an important role in holistically care of this patient group. .

       Conclusion: Nurses are responsible for assessing, monitoring symptoms, maintaining physical and psychosocial aspects, as well as, preventing and controlling infection to decrease the mortality rate and to ensure that patients with CKD infected with COVID-19 are safe and free from adverse effects.

 

       Implication: The proposed knowledge can be used to develop clinical practice guidelines and/or conduct studies related to patients with CKD infected with COVID-19.

 Since knowledge of COVID-19 is constantly changing, healthcare providers should therefore keep up-to-date knowledge continually.

Downloads

Download data is not yet available.

References

World Health Organization. WHO coronavirus 2019 (COVID-19) dashboard [Internet]. 2021 [cited in 2021 Nov 27] Available from: https://covid19.who.int

Department of Disease Control. Coronavirus Disease 2019 (COVID-19) Thailand interactive dashboard [Internet]. 2021 [cited in 2021 Nov 27] Available from: https://ddc.moph.go.th/viralpneumonia/ (in Thai).

World Health Organization. COVID-19 public health emergency of international concern global research and innovation forum [Internet]. 2020 [cited in 2021 Oct 10] Available from: https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum

Wu Z, & McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA 2020;323(13):93-8.

Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HH, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet Glob Health 2020; 8(8):1003-17.

Ortiz A, Cozzolino M, Duivenvoorden R, Fliser D, Fouque D, Franssen C, et al. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant 2021);36(1):87-94.

Lin YC, Lai TS, Lin SL, Chen YM, Chu TS, Tu YK. Outcomes of coronavirus 2019 infection in patients with chronic kidney disease: a systematic review and meta-analysis. Ther Adv Chronic Dis 2021;12:1-13.

Lee AC, Li WT, Apostol L, Ma J, Taub PR, Chang EY, et al. Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: a systematic-review and meta-analysis. Comput Struct Biotechnol J 2021;19:3755-63.

Carney EF. The impact of chronic kidney disease on global health. Nat Rev Nephrol 2020;16(5):251.

World Health Organization. Naming the coronavirus disease 2019 (COVID-19) and the virus that cause it [Internet]. 2020 [cited in 2021 Oct 10] Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

Mahmoud IS, Jarrar YB, Alshaer W, Ismail S. SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention. Biochim Open 2020;175: 93-8.

Sutherasan Y. The basics of COVID-19: the severe covid patients. In: Staworn S, Piyavechvirat K, Morakul S, editors. COVID and crisis in critical care. Bangkok: Beyond Enterprise; 2020. P.37-41. (in Thai)

Chilamakuri R, Agarwal S. COVID-19: characteristics and Therapeutics. Cells Dev 2021; 10(2):1-29.

Department of Disease Control. Guidelines on clinical practice, diagnosis, treatment, and prevention of healthcare-associated infection for COVID-19 updated 4 Aug 2021 for medical professionals and public health personal [Internet]. 2020 [cited in 2021 Oct 10] Available from: https://ddc.moph.go.th/viralpneumonia/eng/file/guidelines/g_CPG_04Aug21.pdf (in Thai).

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2021;395: 497-506.

Adapa S, Chenna A, Balla M, Merugu GP, Koduri NM, Daggubati SR, et al. COVID-19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation. J Clin Med Res 2020;12(6):352-61.

Armaly Z, Kinaneh S, Skorecki K. Renal manifestations of Covid-19: physiology and pathophysiology. J Clin Med 2021;10(6):1-21.

Kaye AD, Okeagu CN, Tortorich G, Pham AD, Ly EI, Brondeel KC, et al. COVID-19 impact on the renal system: pathophysiology and clinical outcomes. Best Pract Res Clin Anaesthesiol 2021;35(3):449-59.

Prasad N, Agrawal SK. COVID 19 and acute kidney injury. Indian J Nephrol 2020;30(3):161-5.

De Boer IH, Caramori ML, Chan JC, Heerspink HJ, Hurst C, Khunti K, et al. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 2020;98(4):S1-S115.

Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, et al. Controversies in acute kidney injury: conclusions from a kidney disease Improving Global Outcomes (KDIGO) Conference. Kidney Int 2020;98(2):294-309.

Thongngam S, Pumool S, Ratanarat R. Nursing care of patients with COVID-19 in isolation unit, Siriraj hospital. Siriraj Medical J 2019;13(3):222-231. (in Thai)

Srisawat N, Tungsanga K. Acute kidney injury. J DMS 2017;42(6):64-8. (in Thai)

Ostermann M, Liu K, Kashani K. Fluid management in acute kidney injury. Chest 2019;156(3):594-603.

Self WH, Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced crystalloids versus saline in critically ill adults. NEJM 2018;378(9):829-39.

Society of Parenteral and Enteral Nutrition of Thailand. Clinical practice recommendation for nutritional management in adult kidney patients [Internet]. 2018 [cited in 2021 Oct 1]. Available from: https://www.spent.or.th/index.php/publication/category/gl/2020 (in Thai)

Arwood MR, Kessler T. Disorder of fluid, electrolytes, and acid-base balance. In: Norris LT, editors. Porth’s pathophysiology: concept of altered health states. 10th ed. Philadelphia: Wolters Kluwer; 2019. p. 158-221.

Trakanvanich T., Kusoom V. Acute kidney injury. In: Kusoom V, editors. Critical care nursing: a holistic approach. 6th ed. Bangkok: Saha Pracha Panich; 2017. p. 561-96. (in Thai)

Chappell L, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19-preliminary report. NEJM 2021;384(8):693-704.

World Health Organization. Corticosteroids for COVID-19: living guidance [Internet]. 2020 [cited in 2021 Oct 10] Available from: https://www.who.int/ publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1.

Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents 2020;55(5):1-6.

Ruiz-Antorán B, Sancho-López A, Torres F, Moreno-Torres V, de Pablo-López I, et al. Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study. Infect Dis Ther 2021;10(1):347-62.

The Nephrology Society of Thailand. Hemodialysis and plasmapheresis clinical practice recommendation [Internet]. 2018 [cited in 2021 Oct 1] Available from: https://www.nephrothai.org/wp-content/uploads/2021/10-2561.pdf (in Thai).

Ruksasuk S. Peritoneal dialysis in critical ill patients. In: Staworn S, Piyavechvirat K, Morakul S, editors. COVID and crisis in critical care. Bangkok: Beyond Enterprise; 2020. p. 567-70. (in Thai).

The Nephrology Society of Thailand, Infectious Disease Association of Thailand. Clinical practice recommendation on the treatment of end stage renal disease patients receiving renal replacement therapy with hemodialysis in COVID-19 (updated 2021 April 9) [Internet]. 2021 [cited in 2021 Nov 25] Available from: https://www.nephrothai.org/wp-content/uploads/2021/04/NST_COVID-19_09-04-21.pdf (in Thai).

The Thai Society of Critical Care Medicine. Clinical practice guideline on the treatment and management of patients with severe COVID-19 (update 23 March 2020) [Internet]. 2020 [cited 2021 Oct 10] Available from: https://tmc.or.th/covid19/ download/pdf (in Thai).

Daorattanachai K. Role of noninvasive ventilation and high-flow nasal cannula in COVID respiratory failure. In: Staworn S, Piyavechvirat K, Morakul S, editors. COVID and crisis in critical care. Bangkok: Beyond Enterprise; 2020. p. 42-55. (in Thai).

Kaur RJ, Charan J, Dutta S, Sharma P, Bhardwaj P, Sharma P, et al. Favipiravir use in COVID-19: Analysis of suspected adverse drug events reported in the WHO database. Infect Drug Resist 2020;13:4427-38.

Picheansathian W. Personal protective equipment for COVID-19 by health care worker. TJNMP 2020;7(1):7-24. (in Thai).

Center for Disease Control and Prevention [CDC]. About COVID-19 Vaccines [Internet]. 2021 [cited in 2021 Nov 23] Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/about-vaccines/index.html

World Health Organization. The different type of COVID-19 vaccines [Internet]. 2021 [cited in 2021 Nov 23] Available from: https://www.who.int/news-room/feature-stories/detail/the-race-for-a-covid-19-vaccine-explained

Center for Disease Control and Prevention. New CDC Study: Vaccination Offers Higher Protection than Previous COVID-19 Infection [Internet]. 2021 [cited in 2021 Nov 29] Available from: New CDC Study: Vaccination Offers Higher Protection than Previous COVID-19 Infection | CDC Online Newsroom | CDC

Published

2022-04-01

How to Cite

1.
Doommai น, Chiaranai จ. Nursing Care of Patients with Chronic Kidney Disease Infected with COVID-19 in Critically ill Condition. JHNR [Internet]. 2022 Apr. 1 [cited 2022 Jun. 26];38(1):1-12. Available from: https://he01.tci-thaijo.org/index.php/bcnbangkok/article/view/252551

Issue

Section

Academic article